Other OTC - Delayed Quote • USD
Willow Biosciences Inc. (CANSF)
At close: 3:53 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -0.1 | 0 |
| Low Estimate | 0 | 0 | -0.1 | 0 |
| High Estimate | 0 | 0 | -0.1 | 0 |
| Year Ago EPS | -- | -- | -0.34 | -0.1 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 500k | 500k | 1.26M | 21.41M |
| Low Estimate | 500k | 500k | 1.26M | 21.41M |
| High Estimate | 500k | 500k | 1.26M | 21.41M |
| Year Ago Sales | -- | 8k | 10k | 1.26M |
| Sales Growth (year/est) | -- | 6,150.00% | 12,500.00% | 1,599.20% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.1 | 0 |
| 7 Days Ago | 0 | 0 | -0.1 | 0.02 |
| 30 Days Ago | 0 | 0 | -0.1 | 0.02 |
| 60 Days Ago | 0 | 0 | -0.1 | 0.02 |
| 90 Days Ago | 0 | 0 | -0.1 | 0.02 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CANSF | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 6.50% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | 70.60% | -- | -- | 5.30% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker